Laboratory analysis of patients with SARS-CoV-2 Infection in a semi-urban COVID-19 center of Lucknow, India
Keywords:
SARS-CoV-2, COVID-19, biochemical biomarker, hematological biomarker, immunological biomarkerAbstract
Timely analysis of the laboratory characteristics associated with 2019 novel coronavirus infection (COVID-19) can assist with clinical diagnosis and prognosis. This study is a collection of clinical data from 100 hospitalized patients diagnosed with COVID-19 in a dedicated COVID- 19 health center located in a semi-urban area from July to September, 2020. The average age of the patients was 50 years. The proportion of patients with comorbidities was 59%. Lymphocyte counts were reduced in the routine blood-work for all patients, but significantly lower in L2-type patients. Elevation of D-Dimer with near normal PT and APTT were detected in coagulation function tests, and more significant changes were observed in L2-type patients compared to L1-type patients. Serum ferritin levels were sensitive to SARS-CoV (severe acute respiratory syndrome coronavirus-2) infection and found to rise in L2-type patients more than L1-type patients. Inflammatory markers, CRP and Interleukin-6 (IL-6) were significantly increased in all patients, but higher in L2-type patients compared to L1-type patients. Coming to organ damage, kidney injury was the most common organ affected by COVID-19 followed by heart and liver.
Downloads
References
Li Y, Tenchov R, Smoot J, Liu C, Watkins S, Zhou Q: A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development. ACS Central Science. 2021 Mar 29;7512-33. 10.1021/acscentsci.1c00120
Belete TM. Review on up-to-date status of candidate vaccines for COVID-19 disease. Infection and drug resistance. 2021;14:151. 10.2147/IDR.S288877
Wang L, Didelot X, Yang J, Wong G, Shi Y, Liu W, Gao GF, Bi Y. Inference of person- to-person transmission of COVID-19 reveals hidden super-spreading events during the early outbreak phase. Nature communications. 2020 Oct 6;11(1):1-6. 10.1038/s41467-020-18836-
World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199–207. 10.1056/nejmoa2001316
Kolifarhood G, Aghaali M, Saadati HM, Taherpour N, Rahimi S, Izadi N, Nazari SS. Epidemiological and clinical aspects of COVID-19; a narrative review. Archives of academic emergency medicine. 2020;8(1).e41.1-9. PMC7117787
Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, Sun C, Sylvia S, Rozelle S, Raat H, Zhou H. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 2020 Dec;9(1):1-2.10.1186/s40249-020-00646-x
Andrews MA, Areekal B, Rajesh KR, Krishnan J, Suryakala R, Krishnan B, Muraly CP, Santhosh PV. First confirmed case of COVID-19 infection in India: A case report. The Indian journal of medical research. 2020 May;151(5):490. 10.4103/ijmr.IJMR_2131_20.
Mathur R. ICMR Consensus Guidelines on ‘Do not attempt resuscitation’. Indian Journal of Medical Research. 2020 Apr 1;151(4):303. 10.4103/ijmr.IJMR_395_20.
Thevarajan I, Buising KL, Cowie BC. Clinical presentation and management of COVID- 19. Med J Aust. 2020 Aug 1;213(3):134-9. 10.5694/mja2.50698
Malhotra S, Rahi M, Das P, Chaturvedi R, Chhibber-Goel J, Anvikar A, Shankar H, Yadav CP, Meena J, Tewari S, Gopinath SV. Epidemiological profiles and associated risk factors of SARS-CoV-2 positive patients based on a high-throughput testing facility in India. Open biology. 2021 Jun 2;11(6):200288. 10.1098/rsob.200288
Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Frontiers in Physiology. 2021 Jan 12;11:1793. 10.3389/fphys.2020.571416
Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta- analysis. Intervirology. 2021;64(1):36-47. 10.1159/000512592.
Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its impact on patients with COVID-19. SN comprehensive clinical medicine. 2020 Jun 25:1-8. 10.1007/s42399-020-00363-4
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal. 2020 May 1;55(5).10.1183/13993003.00547-2020Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. Journal of intensive care. 2020 Dec;8:1-0. 10.1186/s40560-020-00453-4
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, Yuan Z. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Frontiers in immunology. 2020 May 1;11:827. 10.3389/fimmu.2020.00827
Wu D, Wu X, Huang J, Rao Q, Zhang Q, Zhang W. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients. BMC Infectious Diseases. 2021 Dec;21(1):1-2. 10.1186/s12879-021-06354-7.
Wang J, Li Q, Yin Y, Zhang Y, Cao Y, Lin X, Huang L, Hoffmann D, Lu M, Qiu Y. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Frontiers in immunology. 2020 Aug 18;11:2063. 10.3389/fimmu.2020.02063.
Borges L, Pithon-Curi TC, Curi R, Hatanaka E. COVID-19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps. Mediators of Inflammation. 2020 Dec 2;2020. 10.1155/2020/8829674.
Long H, Nie L, Xiang X, Li H, Zhang X, Fu X, Ren H, Liu W, Wang Q, Wu Q. D-dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. BioMed research international. 2020 Oct;2020.10.1155/2020/61597. Wang L, He WB, Yu XM, Hu DL, Jiang H. Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. World Journal of Clinical Cases. 2020 Oct 6;8(19):4370. 10.12998/wjcc.v8.i19.4370 .
Wang L, He WB, Yu XM, Hu DL, Jiang H. Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. World Journal of Clinical Cases. 2020 Oct 6;8(19):4370.
Shimura T, Kurano M, Kanno Y, Ikeda M, Okamoto K, Jubishi D, Harada S, Okugawa S, Moriya K, Yatomi Y. Clot waveform of APTT has abnormal patterns in subjects with COVID-19. Scientific reports. 2021 Mar 4;11(1):1-1. 10.1038/s41598-021-84776-8
Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R, Mai F, Paoloni M, Ferri C, Desideri G, Cicogna S. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Scientific Reports. 2021 Mar 1;11(1):1-1. 10.1038/s41598-021-83831-8
Banchini F, Cattaneo GM, Capelli P. Serum ferritin levels in inflammation: a retrospective comparative analysis between COVID-19 and emergency surgical non- COVID-19 patients. World Journal of Emergency Surgery. 2021 Dec;16(1):1-7. 10.1186/s13017-021-00354-3
Sinha P, Matthay MA, Calfee CS. Is a ―cytokine storm‖ relevant to COVID-19?. JAMA internal medicine. 2020 Sep 1;180(9):1152-4. 10.1001/jamainternmed.2020.3313.
Santa Cruz A, Mendes-Frias A, Oliveira AI, Dias L, Matos AR, Carvalho A, Capela C, Pedrosa J, Castro AG, Silvestre R. IL-6 is a biomarker for the development of fatal SARS-CoV-2 pneumonia. Frontiers in immunology. 2021;12:263. 10.3389/fimmu.2021.613422
Chen Z, Hu J, Liu L, Chen R, Wang M, Xiong M, Li ZQ, Zhao Y, Li H, Guan C, Zhang J. SARS-CoV-2 Causes Acute Kidney Injury by Directly Infecting Renal Tubules. Frontiers in cell and developmental biology. 2021 May 31;9:1245. 10.3389/fcell.2021.664868
Anastasiou OE, Korth J, Herbstreit F, Witzke O, Lange CM. Mild versus severe liver injury in SARS-CoV-2 infection. Digestive Diseases. 2021;39(1):52-7.10.1159/000510758
Published
How to Cite
Issue
Section
Copyright (c) 2021 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
